
Sexual dysfunction remains a common and clinically meaningful consequence of RC. Advances in nerve-sparing and organ-sparing techniques, combined with improved patient selection, counseling, and postoperative rehabilitation, offer the potential to preserve sexual function without compromising oncological outcomes in selected patients. Future progress will depend on standardized, sex-specific outcome reporting, prospective studies, and a multidisciplinary, patient-centered approach to survivorship care.